MONITORING OF RADIOTHERAPY-INDUCED MORPHONUCLEAR MODIFICATIONS IN THE MXT MOUSE MAMMARY-CARCINOMA BY MEANS OF DIGITAL CELL IMAGE-ANALYSIS

被引:21
作者
GASPERIN, P
GOZY, M
PAUWELS, O
FRUHLING, J
VANHOUTTE, P
PASTEELS, JL
KISS, R
机构
[1] INST JULES BORDET,DEPT RADIOTHERAPY,1 RUE HEGER BORDET,B-1000 BRUSSELS,BELGIUM
[2] INST JULES BORDET,DEPT NUCL MED,B-1000 BRUSSELS,BELGIUM
[3] FREE UNIV BRUSSELS,FAC MED,HISTOL LAB,B-1070 BRUSSELS,BELGIUM
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1992年 / 22卷 / 05期
关键词
DIGITAL CELL IMAGE ANALYSIS; RADIOTHERAPY; MXT MOUSE MAMMARY TUMOR; MORPHONUCLEAR MODIFICATIONS;
D O I
10.1016/0360-3016(92)90797-L
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present work deals with the characterization of the morphological changes induced by ionizing radiation on MXT mouse mammary cancer cell nuclei. The monitoring of the radiotherapy-induced morphonuclear modifications was carried out by means of digital cell image analysis, which made it possible to compute morphometric (nuclear area), densitometric (nuclear DNA content) and textural (chromatin pattern characteristics) parameters assessed on Feulgen-stained nuclei. The biological material was obtained from serial fine needle-aspirations performed on control tumors and 2Gy and 8Gy irradiated tumors. Digital cell image analyses were assessed at the 7th, 18th, and 28th days-post irradiation. We showed that radiotherapy induced specific morphonuclear modifications that appeared in a dose-dependent and time-dependent manner. The 2Gy and 8Gy radiotherapy doses led to an increase in the mean nuclear area value, this feature being observed at both the 1st and the 4th week post-irradiation. The resultant effect on the chromatin pattern characteristics corresponded to a decrease in overall condensation level as compared to the control cell nuclei. Finally, the mean nuclear DNA content increased at the 1st week post-irradiation, but decreased at the 4th week post-irradiation as compared to the MXT control tumor. Computerized cell image analysis, therefore, appears to be a useful tool in helping to monitor the radiotherapy-induced effects that occur in neoplastic cell nuclei and which can be observed by means of optical microscopy.
引用
收藏
页码:979 / 987
页数:9
相关论文
共 26 条
[1]  
Alper T, 1979, CELLULAR RADIOBIOLOG
[2]   RADIOTHERAPY ALONE IN BREAST-CANCER .1. ANALYSIS OF TUMOR PARAMETERS, TUMOR DOSE AND LOCAL-CONTROL - THE EXPERIENCE OF THE GUSTAVE-ROUSSY INSTITUTE AND THE PRINCESS MARGARET HOSPITAL [J].
ARRIAGADA, R ;
MOURIESSE, H ;
SARRAZIN, D ;
CLARK, RM ;
DEBOER, G .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1985, 11 (10) :1751-1757
[3]   QUANTITATIVE-EVALUATION OF RADIATION-INDUCED CHANGES IN SPERM MORPHOLOGY AND CHROMATIN DISTRIBUTION [J].
AUBELE, M ;
JUTTING, U ;
RODENACKER, K ;
GAIS, P ;
BURGER, G ;
HACKERKLOM, U .
CYTOMETRY, 1990, 11 (05) :586-594
[4]   DOSE FRACTIONATION, DOSE-RATE AND ISO-EFFECT RELATIONSHIPS FOR NORMAL TISSUE RESPONSES [J].
BARENDSEN, GW .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (11) :1981-1997
[5]  
BARTELS PH, 1983, ANAL QUANT CYTOL, V2, P77
[6]   HYPERSENSITIVITY OF DNA IN TRANSCRIPTIONALLY ACTIVE CHROMATIN TO IONIZING-RADIATION [J].
CHIU, SM ;
OLEINICK, NL ;
FRIEDMAN, LR ;
STAMBROOK, PJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1982, 699 (01) :15-21
[7]   MORPHOLOGY OF MXT MOUSE MAMMARY-TUMORS - CORRELATION WITH GROWTH-CHARACTERISTICS AND HORMONE SENSITIVITY [J].
DANGUY, A ;
KISS, R ;
LECLERCQ, G ;
HEUSON, JC ;
PASTEELS, JL .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (01) :69-75
[8]  
de Launoit Y, 1989, Anal Cell Pathol, V1, P173
[9]   INFLUENCE OF SMEAR PREPARATION AND FIXATIVES ON THE DNA PLOIDY AND THE MORPHONUCLEAR FEATURES OF THE MXT MAMMARY-TUMOR AND NORMAL-TISSUES IN THE MOUSE [J].
DELAUNOIT, Y ;
KISS, R ;
DANGUY, A .
CYTOMETRY, 1990, 11 (06) :691-699
[10]   BASIC RADIOBIOLOGY [J].
HALL, EJ ;
ASTOR, M ;
BEDFORD, J ;
BOREK, C ;
CURTIS, SB ;
FRY, M ;
GEARD, C ;
HEI, T ;
MITCHELL, J ;
OLEINICK, N ;
RUBIN, J ;
TU, A ;
ULLRICH, R ;
WALDREN, C ;
WARD, J .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (03) :220-252